# Engagement as Strategy: Driving Enterprise Value with Life Sciences CEO Christine Miller

Page: https://stenobird.com/podcast/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713/engagement-as-strategy-driving-enterprise-value-with-life-sciences-ceo-christine-miller
Text version: https://stenobird.com/podcast/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713/engagement-as-strategy-driving-enterprise-value-with-life-sciences-ceo-christine-miller.md
Podcast: [The Strategy and Leadership Podcast with Anthony C. Taylor](https://stenobird.com/podcast/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713)
Published: 2026-02-24T19:27:33+00:00
Episode link: https://episode.flightcast.com/r7gn2vauscock6rujcje054c.mp3
Audio file: https://episode.flightcast.com/r7gn2vauscock6rujcje054c.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713/episodes/engagement-as-strategy-driving-enterprise-value-with-life-sciences-ceo-christine-miller
Duration seconds: 1886

## Resource

In many organizations, engagement is treated as a morale metric or a human resources initiative. But what if engagement isn’t a byproduct of strategy — what if it is the strategy? In this episode of the Strategy and Leadership Podcast, host Anthony Taylor sits down with Christine Miller, former CEO of Melinta Therapeutics and seasoned Life Sciences executive, to explore how disciplined strategic planning, structural clarity, and cross-functional alignment can transform enterprise performance. With a background spanning engineering, portfolio leadership, and executive transformation, Christine shares how she helped reshape an organization by building a clear five-year roadmap anchored in four unwavering strategic priorities. Christine explains why engagement cannot be separated from execution. Leaders often chase growth without building the structural foundation required to sustain it. By aligning teams around long-term objectives, reinforcing priorities annually, and resisting the temptation to chase distractions, her organization increased engagement from 69% to 95%, achieved profitability for the first time, and more than doubled revenue. The conversation dives into the realities of leading in complex, highly regulated industries where innovation, regulatory oversight, and stakeholder alignment must coexist. Christine outlines how designing products with patients and payers in mind requires long-term thinking, rigorous data discipline, and iterative strategy — not reactive decision-making. Beyond operational structure, Christine shares insights into leadership visibility and the importance of advocating for both yourself and your team. She reflects on the underrepresentation of women in senior biotech roles and explains how strategic self-promotion, mentorship, and c…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713/episodes/engagement-as-strategy-driving-enterprise-value-with-life-sciences-ceo-christine-miller/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-strategy-and-leadership-podcast-with-anthony-c-taylor-325713/engagement-as-strategy-driving-enterprise-value-with-life-sciences-ceo-christine-miller.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.